SaverOne 2014 Ltd.
Key statistics
from XBRL data in SEC filingsAI briefing
from the latest 10-K, 10-Q and 8-K eventsSaverOne 2014 Ltd. is an Israeli developer of driver-distraction prevention technology whose securities trade on Nasdaq under SVRE (ADSs) and SVREW (warrants).
What they do
SaverOne 2014 Ltd. is incorporated in Israel with principal offices in Petah Tikvah, where it develops technology intended to prevent driver distraction from mobile phone use. It reports under IFRS as issued by the IASB, not U.S. GAAP, and files as a foreign private issuer on Form 20-F. Its ordinary shares have traded on the Tel Aviv Stock Exchange under "SAVR" since June 2020, and its ADSs and warrants began trading on Nasdaq on June 3, 2022.
Revenue drivers
- Driver-distraction prevention products — The filing excerpt identifies the company's activity as computer programming services and driver-distraction prevention technology, but provides no segment revenue breakdown, customer names, or product-level figures.
- No other revenue lines disclosed in excerpt — The provided 20-F excerpt contains no revenue, cost, or profitability figures, so no additional revenue drivers or their relative sizes can be verified.
Recent performance
No revenue, net income, cash flow, or segment results are available in the provided excerpt. The only quantified figures are share-related: 29,961,257,022 ordinary shares outstanding as of December 31, 2025, and ADSs each representing 43,200 ordinary shares per the cover page (the introduction describes each ADS as representing 1,200 ordinary shares, an apparent internal inconsistency). The filing is an annual report on Form 20-F for the fiscal year ended December 31, 2025, filed with the SEC on March 27, 2026. No performance conclusions can be drawn from this excerpt.
Strategy
The provided excerpt does not include management's strategy discussion, MD&A text, or investment priorities beyond the table of contents. It lists Item 5 (Operating and Financial Review and Prospects), Item 4.B (Business Overview), and Item 5.C (Research and Development, Patents and Licenses) as sections of the filing, but the underlying content is not included here. No stated direction, planned investments, or priorities can be reported from this excerpt.
Risks
- Unverified financial condition — The excerpt contains no financial statements or MD&A content, so liquidity, cash burn, and going-concern status cannot be assessed from the source provided.
- Extreme share count — 29,961,257,022 ordinary shares outstanding as of December 31, 2025 implies heavy prior dilution, and the cover page's ratio of 43,200 ordinary shares per ADS conflicts with the introduction's stated 1,200 ratio.
- Foreign private issuer reporting — The company reports under IFRS and files on Form 20-F, so financial statements are not prepared under U.S. GAAP and may not be directly comparable to U.S. peers.
- Warrant overhang — Warrants trade separately on Nasdaq under SVREW, and the terms, exercise prices, and potential dilution are described only in sections of the filing not included in this excerpt.
Outlook
The provided filing excerpt does not contain management's outlook, guidance, or forward-looking commentary. The document includes a table of contents listing a cautionary note regarding forward-looking statements, but that text is not reproduced in the excerpt. No view on future performance can be offered from the source material supplied.